SPOTLIGHT -
Birmingham, AL-A study conducted here at the University of Alabama found that people who take cholesterol-lowering statin drugs are about 50% less likely to have age-related macular degeneration (AMD) than those who do not take the drugs.
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes
(EyePod) From idea to impact: Navigating ophthalmic innovation
The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE
EyePod: Modifier Gene Therapy: What is it?
Verana Health launches its Qdata Thyroid Eye Disease module
Gene editing untangles one strand of the AMD web